A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1992
10/07/1992	EP0507188A1 Substituted 2',3'-dideoxy-5-trifluoromethyluridines, method of their preparation and their use in medicaments
10/07/1992	EP0507160A1 External preparation for application to the skin containing lidocaine
10/07/1992	EP0506982A1 1-azabicyclo 3.2.0]hept-2-ene-2-carboxylic acid compounds
10/07/1992	EP0506965A1 Collagen metabolism ameliorant and its use
10/07/1992	EP0506961A1 External preparation for skin
10/07/1992	EP0506905A1 Piperazine derivatives
10/07/1992	EP0506903A1 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
10/07/1992	EP0506845A1 Uncharged morpholino-based polymers having achiral intersubunit linkages
10/07/1992	EP0506830A1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
10/07/1992	EP0506814A1 Novel products
10/07/1992	EP0506813A1 5-ht 3? antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability
10/07/1992	EP0506801A1 New dihydropyridines
10/07/1992	EP0506792A1 Insulin preparations containing nicotinic acid or nicotinamide.
10/07/1992	EP0506774A1 Smoking substitute.
10/07/1992	EP0506772A1 A pharmaceutical composition comprising a phosphosugar
10/07/1992	EP0506769A1 Pharmaceutical composition for treating or preventing retroviral infections.
10/07/1992	EP0506759A1 Therapeutically active fluoro substituted benzimidazoles, processes for their preparation as well as their use
10/07/1992	EP0506729A1 Pharmaceutically active oxazole compounds
10/07/1992	EP0493380A4 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/07/1992	CN1065070A 6,7-modified 11beta-aryl-4-estrene
10/07/1992	CN1065069A Process for preparing erythromycin derivatives
10/07/1992	CN1065066A Process for preparing castano spermine glycosides
10/07/1992	CN1065065A Process for preparing 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/07/1992	CN1065063A 1-biphenylmethyl imidazole derivatives, their preparation and their therapeutic use
10/07/1992	CN1065062A Quinoline-containing ketoacids as leukotriene antagonists
10/07/1992	CN1065010A Steroid formultions
10/07/1992	CN1065009A Process for preparing composition for beauty or pharmaceutical, especially dermtoses and anti-allergy and use
10/07/1992	CN1018548B Carboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions containing them
10/07/1992	CA2107667A1 Atp analogues
10/06/1992	WO1992017440A1 Tricyclic compound
10/06/1992	USRE34091 Sialic acid derivatives having active carbonyl group
10/06/1992	USRE34089 Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant
10/06/1992	US5153353 Antilipemic agents
10/06/1992	US5153318 Viricides for hepatitis and human t-cell leukemia/lymphoma viruses
10/06/1992	US5153312 Respiratory system disorders
10/06/1992	US5153228 9-amino-2-phenylbicyclo[3.3.1]nonanes and 9-amino-2-phenylbicyclo[3.3.1]non-2-enes and drugs containing them
10/06/1992	US5153227 Phenylsulfonyl nitromethanes as aldose reductase inhibitors
10/06/1992	US5153226 Acat inhibitors for treating hypocholesterolemia
10/06/1992	US5153225 For treating disorders of the central nervous system, cardiovascular system and intestinal tract
10/06/1992	US5153222 Method of treating pulmonary hypertension with benzidine prostaglandins
10/06/1992	US5153221 Method for the treatment of acquired immune deficiency syndrome
10/06/1992	US5153219 Thiocarbamate sulfoxide composition for deterring ethanol ingestion
10/06/1992	US5153216 Method for treating chest pain
10/06/1992	US5153214 Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
10/06/1992	US5153212 For human or veterinary use
10/06/1992	US5153210 Compounds
10/06/1992	US5153206 Neuroleptic agents for treating psychological disorders
10/06/1992	US5153205 Method to reduce introacular pressure without causing miosis
10/06/1992	US5153202 Method of inhibiting the activity of human immuno deficiency virus (HIV) in vivo
10/06/1992	US5153198 Agent for treatment of disorders of the cerebro-neural transmission system
10/06/1992	US5153196 Administering for reduction of neurotransmission in nervous system disorders
10/06/1992	US5153193 Nootropic, cholinergic agents
10/06/1992	US5153192 For controlling intraocular pressure
10/06/1992	US5153191 Cholecystokinin antagonists useful for treating depression
10/06/1992	US5153190 Pyrrolo [1,2A] thieno [3,2-F] [1,4] diazepines
10/06/1992	US5153188 Thienamycin antibiotics
10/06/1992	US5153187 1-methylcarbapenem derivatives and process for preparation thereof
10/06/1992	US5153183 Methylenediphosphonic acid compounds and methods of use for the treatment of rheumatism and osteophorosis
10/06/1992	US5153181 Administering a polysaccharides containing sulfate groups
10/06/1992	US5153178 Compositions and method of treatment for improving circulatory performance
10/06/1992	US5153174 Polymer mixtures useful in skin care
10/06/1992	US5153012 Mixing beta-carotene with anti-oxidative vitamin C, vitamin B2 and vitamin E to minimize the loss of carotene
10/06/1992	US5153001 Oral administration of mixture of nifedipine and vitamin E to increase fluidity of circulating blood, vasodilation
10/06/1992	US5152994 Rapid method for interrupting or attenuating poly-drug dependency syndromes
10/06/1992	US5152986 Preparation and use of ion exchange resins loaded with quinolonecarboxylic acid derivatives
10/06/1992	US5152979 Method for treating vascular obstructions caused by abnormal cells
10/06/1992	US5152978 Sulphated vinyl polymers in compositions for treating retroviral infections
10/06/1992	CA2106979A1 Tricyclic compound
10/06/1992	CA2065083A1 Topical 5-fluorouracil prodrug composition and method
10/06/1992	CA2065061A1 Benzimidazole-derived non sedative antihistamines
10/06/1992	CA2064985A1 8a-aza-8a-homoertyhromycin cyclic lactams
10/06/1992	CA2064918A1 Compositions having a physiological cooling effect and active compounds suitable for these compositions
10/06/1992	CA2064916A1 Substituted 2', 3'-dideoxy-5-trifluoromethyluridines, processes for their preparation and their use in medicaments
10/06/1992	CA2064654A1 Substituted quinolines as angiotensin ii antagonists
10/06/1992	CA2063912A1 Analgesic use of benzobicyclic carboxamides
10/06/1992	CA1308417C Process for the preparation of baccatine iii and deacetyl-10-baccatine iii
10/06/1992	CA1308416C Phenylalkyl-2,3-dihydrobenzofurans and analogs useful as anti-inflammatory agents
10/06/1992	CA1308414C 1-arylsulfonyl-1,5-dihydro-2h-pyrrol-2-one derivatives; process and intermediates for preparing them; their use as drugs; compositons containing them
10/06/1992	CA1308413C Pyridazinone derivatives
10/06/1992	CA1308412C Process for the production of phthalazineacetic acid esters derivatives and a novel intermediate
10/06/1992	CA1308358C Antibacterial lyophilized preparation
10/05/1992	WO1992017472A1 Novel thiophene-2-carboxylic acid derivatives and process for their production
10/05/1992	WO1992017451A1 Pyridine- and imidazole-derived agents for cardiovascular diseases
10/05/1992	WO1992017161A1 Chewable antacid compositions
10/05/1992	CA2107662A1 Novel thiophene-2-carboxylic acid derivatives and process for their production
10/04/1992	CA2064924A1 Piperidine derivatives, their preparation and their therapeutic application
10/04/1992	CA2064678A1 Method of treating diabetes
10/03/1992	WO1992017173A2 Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria
10/03/1992	CA2107078A1 Use of riboflavin in the treatment of hiv-linked diseases, herpes, retinitis pigmentosa and malaria
10/02/1992	WO1992017177A1 Ibuprofen-antitussive combinations
10/02/1992	WO1992017171A1 Ibuprofen-decongestant combinations
10/02/1992	WO1992017152A2 Method for detecting and treating alzheimer's disease
10/02/1992	CA2107589A1 Method for detecting and treating alzheimer's disease
10/02/1992	CA2107332A1 Ibuprofen-antitussive combinations
10/02/1992	CA2107331A1 Ibuprofen-decongestant combinations
10/02/1992	CA2064550A1 Tyrosine phosphorylation in protozoans
10/02/1992	CA2064149A1 Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
10/02/1992	CA2063962A1 Silyl ethers of rapamycin
10/01/1992	WO1992017025A2 GnRH ANALOGS
10/01/1992	WO1992016666A1 N6-(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body

1 ... 7243 7244 7245 7246 7247 7248 7249 7250 7251 7252 7253 7254 7255 7256 7257 7258 7259 7260 7261 7262 7263 ... 7860